TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT
6.1. Overview
6.2. Recombinant Non-glycosylated Proteins
6.3. Recombinant Glycosylated Proteins
7. GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY
7.1. Overview
7.2. Mammalian
7.3. Non-Mammalian
8. GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION
8.1. Overview
8.2. Oncology
8.3. Blood Disorders
8.4. Growth Hormonal Deficiency
8.5. Chronic & Autoimmune Disorders
8.6. Rheumatoid Arthritis
8.7. Others
9. GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Biosimilar contract manufacturing Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Biosimilar contract manufacturing Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Production Technology Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Boehringer Ingelheim GmbH
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Lonza
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Catalent Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Biocon
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. IQVIA Inc.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. AGC BIOLOGICS.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Samsung Biologics
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. WuXi Biologics
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Element Materials Technology.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Rentschler Biopharma SE
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Avid Bioservice, Inc.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Alcami Corporation, Inc.
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Fujifilm Kyowa Kirin Biologics Co., Ltd.
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Thermo Fisher Scientific Inc
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Products Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
11.15. Almac Group
11.15.1. Company Overview
11.15.2. Financial Overview
11.15.3. Products Offered
11.15.4. Key Developments
11.15.5. SWOT Analysis
11.15.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 10 U.S. BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 11 U.S. BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 12 U.S. BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 CANADA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 14 CANADA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 15 CANADA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 16 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 17 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 18 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 20 GERMANY BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 21 GERMANY BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 22 GERMANY BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 FRANCE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 24 FRANCE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 25 FRANCE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 26 ITALY BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 27 ITALY BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 28 ITALY BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 SPAIN BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 30 SPAIN BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 31 SPAIN BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 U.K BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 33 U.K BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 34 U.K BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 36 REST OF EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 37 REST OF EUROPE BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 38 ASIA PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 39 ASIA PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 40 ASIA PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 41 ASIA PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 42 JAPAN BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 43 JAPAN BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 44 JAPAN BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 45 CHINA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 46 CHINA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 47 CHINA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 INDIA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 49 INDIA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 50 INDIA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 AUSTRALIA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 52 AUSTRALIA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 53 AUSTRALIA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 54 SOUTH KOREA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 55 SOUTH KOREA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 56 SOUTH KOREA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 57 REST OF ASIA-PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 58 REST OF ASIA-PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 59 REST OF ASIA-PACIFIC BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 60 REST OF WORLD BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 61 REST OF WORLD BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 62 REST OF WORLD BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 63 REST OF WORLD BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 64 MIDDLE EAST BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 65 MIDDLE EAST BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 66 MIDDLE EAST BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 67 AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 68 AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 69 AFRICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 70 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 71 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD BILLION)
TABLE 72 LATIN AMERICA BIOSIMILAR CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2018-2032 (USD BILLION) 
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET
FIGURE 4 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 5 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY PRODUCTION TECHNOLOGY, 2022
FIGURE 6 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: BIOSIMILAR CONTRACT MANUFACTURING MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 BOEHRINGER INGELHEIM GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS
FIGURE 15 LONZA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 LONZA: SWOT ANALYSIS
FIGURE 17 CATALENT INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 CATALENT INC.: SWOT ANALYSIS
FIGURE 19 BIOCON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 BIOCON: SWOT ANALYSIS
FIGURE 21 IQVIA INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 IQVIA INC..: SWOT ANALYSIS
FIGURE 23 AGC BIOLOGICS.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 AGC BIOLOGICS.: SWOT ANALYSIS
FIGURE 25 SAMSUNG BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 SAMSUNG BIOLOGICS: SWOT ANALYSIS
FIGURE 27 WUXI BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 WUXI BIOLOGICS: SWOT ANALYSIS
FIGURE 29 ELEMENT MATERIALS TECHNOLOGY.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 ELEMENT MATERIALS TECHNOLOGY.: SWOT ANALYSIS
FIGURE 31 RENTSCHLER BIOPHARMA SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 RENTSCHLER BIOPHARMA SE: SWOT ANALYSIS
FIGURE 33 AVID BIOSERVICE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 AVID BIOSERVICE, INC.: SWOT ANALYSIS
FIGURE 35 ALCAMI CORPORATION, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 ALCAMI CORPORATION, INC: SWOT ANALYSIS
FIGURE 37 FUJIFILM KYOWA KIRIN BIOLOGICS CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 FUJIFILM KYOWA KIRIN BIOLOGICS CO., LTD.: SWOT ANALYSIS
FIGURE 39 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 41 ALMAC GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 ALMAC GROUP: SWOT ANALYSIS
